These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Management for patients with advanced T4 epidermoid carcinoma of the esophagus. Wang LS, Chi KH, Hu MH, Fahn HJ, Huang MH. J Surg Oncol; 1996 May; 62(1):22-9. PubMed ID: 8618396 [Abstract] [Full Text] [Related]
34. Dose-response relationship in locoregional control for patients with stage II-III esophageal cancer treated with concurrent chemotherapy and radiotherapy. Zhang Z, Liao Z, Jin J, Ajani J, Chang JY, Jeter M, Guerrero T, Stevens CW, Swisher S, Ho L, Yao J, Allen P, Cox JD, Komaki R. Int J Radiat Oncol Biol Phys; 2005 Mar 01; 61(3):656-64. PubMed ID: 15708243 [Abstract] [Full Text] [Related]
35. A planned neck dissection is not necessary in all patients with N2-3 head-and-neck cancer after sequential chemoradiotherapy. Soltys SG, Choi CY, Fee WE, Pinto HA, Le QT. Int J Radiat Oncol Biol Phys; 2012 Jul 01; 83(3):994-9. PubMed ID: 22137026 [Abstract] [Full Text] [Related]
39. Capecitabine and cisplatin chemotherapy (XP) alone or sequentially combined chemoradiotherapy containing XP regimen in patients with three different settings of stage IV esophageal cancer. Lee SS, Kim SB, Park SI, Kim YH, Ryu JS, Song HY, Shin JH, Jung HY, Lee GH, Choi KD, Cho KJ, Kim JH. Jpn J Clin Oncol; 2007 Nov 01; 37(11):829-35. PubMed ID: 17951334 [Abstract] [Full Text] [Related]